GSK to spend up to £1.1bn in deal for access to unique asthma treatment January 9, 2024 GSK, formerly known as Glaxosmithkline, has agreed to acquire biopharmaceutical company Aiolos Bio in a deal worth at least $1bn (£785m), as it hails access to the latter company's twice-yearly asthma treatment.
GSK’s blood cancer drug shows promise in late-stage trial November 27, 2023 GSK said on Monday its blood cancer drug Blenrep, when used as a second-line treatment in patients with myeloma, met its primary goal.
FTSE 100 close: London rises on strong Next results as investors await Fed rate decision November 1, 2023 The Fed is widely expected to leave interest rates on hold as it assesses how its historic bout of monetary tightening is impacting inflation.
GSK hikes outlook after launch of new RVS vaccine – despite reduction in Covid sales November 1, 2023 GSK said it is still firmly growing despite the significant reduction in sales of Covid-19 products over recent years.
GSK settles ‘bellwether’ Zantac cases out of court October 11, 2023 Pharmaceutical giant GSK said today it has reached a "confidential settlement" over several lawsuits filed in California.
GSK raises £886m after offloading chunk of Haleon shares October 6, 2023 GSK has pocketed £886m after offloading a chunk of its stake in the spun off consumer healthcare arm Haleon, the firm announced this morning. The FTSE 100 healthcare giant announced yesterday that it would sell some 270m in ordinary shares at a price of 328p per share. The sale has now slashed the size of [...]
GSK: British drugmaker raises profit and sales guidance after earnings beat expectations July 26, 2023 GSK raised its full-year profit and sales guidance on Wednesday after its second-quarter earnings beat expectations, helped by strong sales of its shingles vaccine Shingrix and HIV medicines. The strong results may further help revive investor confidence in CEO Emma Walmsley, coming a year after the company spun off its consumer health business, Haleon, in its most [...]
GSK settles lawsuit over heartburn drug Zantac with alleged cancer links but ‘admits no liability’ June 23, 2023 Pharmaceutical giant GSK has revealed it has settled a lawsuit relating to discontinued heartburn drug Zantac, which was alleged to be linked to cancer. Shares in GSK jumped after it said an upcoming trial was cancelled but that it does not admit liability. The company hit back at allegations last year that the use of [...]
GSK offloads £804m worth of shares in spun out healthcare arm Haleon May 12, 2023 British drugmaker GlaxoSmithKline (GSK) has today offloaded some 240m shares of its spun out consumer healthcare group Haleon in a move which has raised £804m for the firm.
Haleon: Flu season and Chinese pain relief give GSK spin-out a boost May 3, 2023 A “strong” cold and flu season and the end of Chinese lockdowns contributed to a healthy revenue boost for Haleon, the spin-out of GSK’s consumer healthcare division. Organic revenues within the group were up 9.9 per cent, with operating profit hitting £627m – reflecting a large reduction in the costs of spinning out the business [...]